Melanotan I

What this is

An alpha-MSH analog. Afamelanotide is the active in an FDA-approved subcutaneous implant for a narrow indication.

Evidence position

Grade A. The approved product is a 16 mg implant — a lyophilised vial is a materially different presentation. No pigmentation, tanning or photoprotection claim is supportable.

What the record does not establish

Published research about a molecule is not a test of any particular vial. Identity, purity, strength and microbiological quality are established by lot-level analytical records tied to a matched sample — not by the literature, and not by the presence of an approved comparator.

Where a lot-level record exists it is published on the evidence page and linked from the product. Where it does not exist, the record says so.